Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Discovery of novel highly potent hepatitis C virus NS5A inhibitor (AV4025).
Ivachtchenko AV, Mitkin OD, Yamanushkin PM, Kuznetsova IV, Bulanova EA, Shevkun NA, Koryakova AG, Karapetian RN, Bichko VV, Trifelenkov AS, Kravchenko DV, Vostokova NV, Veselov MS, Chufarova NV, Ivanenkov YA. Ivachtchenko AV, et al. Among authors: ivanenkov ya. J Med Chem. 2014 Sep 25;57(18):7716-30. doi: 10.1021/jm500951r. Epub 2014 Sep 9. J Med Chem. 2014. PMID: 25148100
Novel mitotic targets and their small-molecule inhibitors.
Ivachtchenko AV, Kiselyov AS, Tkachenko SE, Ivanenkov YA, Balakin KV. Ivachtchenko AV, et al. Among authors: ivanenkov ya. Curr Cancer Drug Targets. 2007 Dec;7(8):766-84. doi: 10.2174/156800907783220499. Curr Cancer Drug Targets. 2007. PMID: 18220536 Review.
Novel aryl and heteroaryl substituted N-[3-(4-phenylpiperazin-1-yl)propyl]-1,2,4-oxadiazole-5-carboxamides as selective GSK-3 inhibitors.
Koryakova AG, Ivanenkov YA, Ryzhova EA, Bulanova EA, Karapetian RN, Mikitas OV, Katrukha EA, Kazey VI, Okun I, Kravchenko DV, Lavrovsky YV, Korzinov OM, Ivachtchenko AV. Koryakova AG, et al. Among authors: ivanenkov ya. Bioorg Med Chem Lett. 2008 Jun 15;18(12):3661-6. doi: 10.1016/j.bmcl.2007.11.121. Epub 2007 Dec 5. Bioorg Med Chem Lett. 2008. PMID: 18502121
CXCR4 receptor as a promising target for oncolytic drugs.
Lavrovsky Y, Ivanenkov YA, Balakin KV, Medvedeva DA, Ivachtchenko AV. Lavrovsky Y, et al. Among authors: ivanenkov ya. Mini Rev Med Chem. 2008 Oct;8(11):1075-87. doi: 10.2174/138955708785909907. Mini Rev Med Chem. 2008. PMID: 18855724 Review.
5-HT(6) receptor modulators: a patent update. Part 2. Diversity in heterocyclic scaffolds.
Ivachtchenko AV, Ivanenkov YA, Skorenko AV. Ivachtchenko AV, et al. Among authors: ivanenkov ya. Expert Opin Ther Pat. 2012 Oct;22(10):1123-68. doi: 10.1517/13543776.2012.722205. Epub 2012 Sep 7. Expert Opin Ther Pat. 2012. PMID: 22957857 Review.
AREAS COVERED: The current paper is an update to the comprehensive review article published previously in Expert Opinion on Therapeutic Patents [1] Ivashchenko AV, Ivanenkov YA, Tkachenko SE. 5-Hydroxytryptamine subtype 6 receptor modulators: a patent survey. ...
AREAS COVERED: The current paper is an update to the comprehensive review article published previously in Expert Opinion on Therapeutic Pate …
Small-molecule arginase inhibitors.
Ivanenkov YA, Chufarova NV. Ivanenkov YA, et al. Pharm Pat Anal. 2014 Jan;3(1):65-85. doi: 10.4155/ppa.13.75. Pharm Pat Anal. 2014. PMID: 24354980 Review.
A novel influenza virus neuraminidase inhibitor AV5027.
Ivachtchenko AV, Ivanenkov YA, Mitkin OD, Yamanushkin PM, Bichko VV, Leneva IA, Borisova OV. Ivachtchenko AV, et al. Among authors: ivanenkov ya. Antiviral Res. 2013 Dec;100(3):698-708. doi: 10.1016/j.antiviral.2013.10.008. Antiviral Res. 2013. PMID: 24416774
85 results